Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Cash from Operations (2016 - 2025)

Apyx Medical's Cash from Operations history spans 15 years, with the latest figure at 2530000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 13.86% year-over-year to 2530000.0; the TTM value through Dec 2025 reached 8001000.0, up 55.67%, while the annual FY2025 figure was 8001000.0, 55.67% up from the prior year.
  • Cash from Operations reached 2530000.0 in Q4 2025 per APYX's latest filing, up from 3536000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 3696000.0 in Q3 2023 to a low of 6341000.0 in Q1 2024.
  • Average Cash from Operations over 5 years is 3101300.0, with a median of 3570500.0 recorded in 2021.
  • Peak YoY movement for Cash from Operations: crashed 2216.82% in 2022, then surged 168.96% in 2023.
  • A 5-year view of Cash from Operations shows it stood at 214000.0 in 2021, then plummeted by 2216.82% to 4530000.0 in 2022, then soared by 51.17% to 2212000.0 in 2023, then plummeted by 32.78% to 2937000.0 in 2024, then rose by 13.86% to 2530000.0 in 2025.
  • Per Business Quant, the three most recent readings for APYX's Cash from Operations are 2530000.0 (Q4 2025), 3536000.0 (Q3 2025), and 1233000.0 (Q2 2025).